INS and Hyperglycemia: In the present study, the different medicaments revealed improvement in the islets morphology and an increase in the insulin content of β-cells of the pancreatic islets, especially with GLB+VGN-20 treatment, which appeared in the form of reducing the hyperglycemia in this group.